Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study

INTRODUCTION: Methamphetamine misuse is classified as a ‘likely’ risk factor for pulmonary arterial hypertension (PAH). Nevertheless, the actual prevalence of and a screening strategy for PAH in methamphetamine users have not been established. We plan to study the prevalence of PAH and identify its...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yangyang, Tung, Chi-Kwong, Chung, Albert Kar Kin, Liu, Wan-Wan, Huang, Duo, Chan, Pak Hei, Lam, Ming, Chan, Wai-Chi, Siu, Chung-Wah, Hai, Jo Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688696/
https://www.ncbi.nlm.nih.gov/pubmed/31375608
http://dx.doi.org/10.1136/bmjopen-2018-027193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688696/
https://www.ncbi.nlm.nih.gov/pubmed/31375608
http://dx.doi.org/10.1136/bmjopen-2018-027193

Ejemplares similares